Mitali Chatterjee Selected Research

Mitali Chatterjee Research Topics

Disease

26	Leishmaniasis 04/2022 - 01/2007
25	Visceral Leishmaniasis (Kala Azar) 03/2022 - 05/2003
21	Neoplasms (Cancer) 08/2017 - 04/2008
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2016 - 05/2004
8	Rheumatoid Arthritis 06/2022 - 05/2011
7	Inflammation (Inflammations) 05/2021 - 09/2008
6	Infections 04/2022 - 11/2010
6	Disease Progression 01/2022 - 09/2011
6	Arthritis (Polyarthritis) 03/2020 - 05/2007
6	Carcinoma (Carcinomatosis) 12/2016 - 09/2011
6	Ascites 12/2016 - 09/2011
5	Edema (Dropsy) 02/2017 - 11/2010
4	Tuberculosis (Tuberculoses) 04/2022 - 10/2013
4	Malaria 01/2020 - 08/2015
4	Leukemia 12/2016 - 05/2011
3	Vitiligo 12/2017 - 11/2014
3	Body Weight (Weight, Body) 09/2012 - 07/2010
2	Cutaneous Leishmaniasis 08/2022 - 05/2012
2	Autoimmune Diseases (Autoimmune Disease) 06/2022 - 11/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 11/2015
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2014
2	Necrosis 06/2018 - 01/2012
2	Experimental Arthritis 06/2018 - 02/2017
1	Osteoarthritis 10/2021
1	Glucose Intolerance 07/2021
1	Ankylosing Spondylitis 05/2021
1	Shock 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Hypertension (High Blood Pressure) 03/2018

Drug/Important Bio-Agent (IBA)

19	Pharmaceutical PreparationsIBA 01/2022 - 09/2009
9	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 01/2007
8	CytokinesIBA 01/2021 - 09/2009
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2016 - 06/2010
7	AntimonyIBA 12/2014 - 02/2007
6	Proteins (Proteins, Gene)FDA Link 07/2019 - 06/2008
5	Free RadicalsIBA 05/2021 - 05/2011
5	artemisinin (artemisinine)IBA 01/2019 - 09/2007
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2012 - 06/2010
4	Methotrexate (Mexate)FDA LinkGeneric 06/2022 - 11/2015
4	Interleukin-10 (Interleukin 10)IBA 11/2021 - 06/2008
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2021 - 01/2011
4	Freund's AdjuvantIBA 03/2020 - 05/2007
4	IronIBA 01/2020 - 02/2012
4	AntioxidantsIBA 07/2019 - 05/2011
4	CopperIBA 12/2016 - 09/2009
4	miltefosine (Impavido)IBA 10/2015 - 11/2011
4	CarrageenanIBA 01/2015 - 11/2010
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2012
3	EnzymesIBA 01/2021 - 09/2004
3	LipopolysaccharidesIBA 03/2020 - 03/2013
3	Oxidants (Oxidizing Agents)IBA 07/2019 - 12/2012
3	allylpyrocatecholIBA 06/2018 - 05/2011
3	malabaricone AIBA 10/2016 - 01/2015
3	gluconic acid (gluconate)FDA LinkGeneric 12/2014 - 02/2007
3	SodiumIBA 12/2014 - 02/2007
2	pyrimidineIBA 04/2022 - 04/2022
2	liposomal amphotericin B FDA Link 03/2022 - 01/2019
2	Immunoglobulin G (IgG)IBA 11/2021 - 06/2008
2	ImmunosorbentsIBA 01/2021 - 09/2004
2	AntigensIBA 03/2020 - 11/2010
2	Collagen Type II (Type II Collagen)IBA 03/2020 - 06/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2012
2	Biological ProductsIBA 01/2018 - 01/2015
2	CaspasesIBA 08/2017 - 08/2010
2	Schiff Bases (Schiff Base)IBA 08/2017 - 12/2016
2	catalase-polyethylene glycolIBA 12/2016 - 01/2012
2	Dextrans (Dextran)FDA Link 01/2015 - 01/2012
2	Glutathione (Reduced Glutathione)IBA 02/2012 - 01/2012
2	multidrug resistance-associated protein 1IBA 02/2012 - 01/2012
2	MetalsIBA 11/2011 - 06/2010
2	ResveratrolIBA 08/2010 - 06/2008
2	AntibodiesIBA 02/2006 - 05/2004
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 09/2004 - 05/2003
1	ascaridoleIBA 08/2022
1	indoleIBA 04/2022
1	6-aminouracilIBA 04/2022
1	resazurinIBA 04/2022
1	ChalconesIBA 04/2022
1	Insulin (Novolin)FDA Link 07/2021
1	Glucose (Dextrose)FDA LinkGeneric 07/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 07/2021
1	Vasodilator Agents (Vasodilators)IBA 05/2021
1	NitritesIBA 05/2021
1	Interleukin-13IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	EmulsionsIBA 03/2020
1	Ribosomal DNA (rDNA)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	Heme (Haem)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 06/2018
1	CollagenIBA 06/2018
1	Desoxycorticosterone Acetate (DOCA)FDA Link 03/2018
1	cortexinIBA 03/2018
1	SaltsIBA 03/2018
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 03/2018

Therapy/Procedure

13	Therapeutics 06/2022 - 06/2007
11	Drug Therapy (Chemotherapy) 12/2014 - 05/2004
3	Immunomodulation 01/2016 - 08/2010
1	Aftercare (After-Treatment) 10/2021
1	Compressed Air 01/2021